Wednesday, June 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “mycophenolate” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 11
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 11 pipeline programs matching "mycophenolate" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

11 results for “mycophenolate” Back to intelligence hub

Search results

  1. Mycophenolate Mofetil

    Cardiff Oncology

    Immune Thrombocytopenia

    phase 3 small molecule completed

    1 trial
  2. mycophenolate mofetil (CellCept)

    Hoffmann-La Roche

    Myasthenia Gravis, Generalized

    phase 3 small molecule completed

    1 trial
  3. mycophenolate mofetil 2 g per day

    The First People's Hospital of Lianyungang

    Lymphocytic Myocarditis (Disorder)

    phase 3 small molecule completed

    1 trial
  4. Mycophenolate Mofetil

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    4 trials
  5. Mycophenolate Mofetil

    BRIGHT MINDS BIOSCIENCES INC.

    Hematopoietic Stem Cell Transplantation

    phase 1 small molecule active

    1 trial
  6. Enteric-Coated Mycophenolate Sodium (EC-MPS)

    Novartis Pharmaceuticals

    Renal Transplant

    approved small molecule completed

    1 trial
  7. Methylprednisolone and Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hepatitis

    approved small molecule active

    1 trial
  8. SIMA SPK 01

    The George Institute

    End-stage kidney disease in Type 1 diabetes, SIROLIMUS VERSUS MYCOPHENOLATE MOFETIL IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION TO EVALUATE THE RISK OF HERNIA

    approved small molecule active

    1 trial
  9. mycophenolate mofetil

    United Therapeutics Europe Ltd

    IGA Nephropathy

    approved small molecule completed

    1 trial
  10. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial
  11. Tacrolimus+Mycophenolate mofetil

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lupus Nephritis

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.